SEC Company Response from Altimmune, Inc. (ALT) (CIK 0001326190) (ALT) — Sep 27, 2018
Altimmune, Inc. (ALT) (CIK 0001326190)
Date: Sept. 27, 2018 · CIK: 0001326190 · Accession: 0001193125-18-285764
AI Filing Summary & Sentiment
File numbers found in text: 333-226441
Show Raw Text
CORRESP 1 filename1.htm UW Acceleration Request Roth Capital Partners, LLC 888 San Clemente Drive Newport Beach, CA 92660 September 27, 2018 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Altimmune, Inc. (the “Company”) Registration Statement on Form S-1 (File No. 333-226441) Ladies and Gentlemen: In connection with the above-captioned registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Roth Capital Partners, LLC, as the sole underwriter, hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 5:00 p.m. (Eastern time) on Thursday, September 27, 2018, or as soon thereafter as practicable. In making this request the undersigned acknowledges that it is aware of its obligations under the Act as they relate to the public offering of securities pursuant to the registration statement. [Signature Page Follows] Very truly yours, ROTH CAPITAL PARTNERS, LLC, As the Sole Underwriter By: /s/ Aaron M. Gurewitz Name: Title: Aaron M. Gurewitz Head of Equity Capital Markets